H M Katzenstein

Summary

Affiliation: Northwestern University
Country: USA

Publications

  1. ncbi request reprint Fibrolamellar hepatocellular carcinoma in children and adolescents
    Howard M Katzenstein
    Department of Pediatrics, Children s Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA
    Cancer 97:2006-12. 2003
  2. ncbi request reprint Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience
    H M Katzenstein
    Department of Pediatrics, Northwestern University and Children s Memorial Hospital, Chicago, IL 60614, USA
    J Clin Oncol 19:1047-55. 2001
  3. ncbi request reprint Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study
    Howard M Katzenstein
    Department of Pediatrics and Surgery, Northwestern University and Children s Memorial Hospital, Chicago, IL, USA
    J Clin Oncol 20:2789-97. 2002
  4. ncbi request reprint MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN
    S L Cohn
    Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois, USA
    J Clin Oncol 18:3604-13. 2000
  5. ncbi request reprint Antiangiogenic therapy inhibits human neuroblastoma growth
    H M Katzenstein
    Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School and Children's Memorial Hospital, Chicago, Illinois 60614, USA
    Med Pediatr Oncol 36:190-3. 2001
  6. ncbi request reprint Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma
    Rebecka L Meyers
    Division of Pediatric Surgery, Primary Children s Medical Center, University of Utah, Salt Lake City, UT 84113, USA
    J Pediatr Surg 42:2050-6. 2007
  7. ncbi request reprint Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents
    Sharon B Murphy
    Children s Cancer Research Institute, University of Texas Health Science Center, San Antonio 78229, USA
    J Pediatr Hematol Oncol 25:684-7. 2003
  8. ncbi request reprint Metastatic malignant rhabdoid tumor of the liver treated with tandem high-dose therapy and autologous peripheral blood stem cell rescue
    Howard M Katzenstein
    Med Pediatr Oncol 40:199-201. 2003
  9. doi request reprint Redefining the role of doxorubicin for the treatment of children with hepatoblastoma
    Marcio H Malogolowkin
    Childrens Hospital Los Angeles, Division of Hematology Oncology, 4650 Sunset Blvd, MS 54, Los Angeles, CA 90027, USA
    J Clin Oncol 26:2379-83. 2008
  10. ncbi request reprint Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study
    Morris Kletzel
    Department of Pediatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
    J Clin Oncol 20:2284-92. 2002

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Fibrolamellar hepatocellular carcinoma in children and adolescents
    Howard M Katzenstein
    Department of Pediatrics, Children s Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA
    Cancer 97:2006-12. 2003
    ....
  2. ncbi request reprint Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience
    H M Katzenstein
    Department of Pediatrics, Northwestern University and Children s Memorial Hospital, Chicago, IL 60614, USA
    J Clin Oncol 19:1047-55. 2001
    ....
  3. ncbi request reprint Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study
    Howard M Katzenstein
    Department of Pediatrics and Surgery, Northwestern University and Children s Memorial Hospital, Chicago, IL, USA
    J Clin Oncol 20:2789-97. 2002
    ....
  4. ncbi request reprint MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN
    S L Cohn
    Department of Pediatrics, Northwestern University Medical School, Chicago, Illinois, USA
    J Clin Oncol 18:3604-13. 2000
    ..To determine the prognostic significance of MYCN expression in the absence of MYCN amplification, we analyzed MYCN mRNA and protein expression in tumors from 69 patients...
  5. ncbi request reprint Antiangiogenic therapy inhibits human neuroblastoma growth
    H M Katzenstein
    Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School and Children's Memorial Hospital, Chicago, Illinois 60614, USA
    Med Pediatr Oncol 36:190-3. 2001
    ..We speculate that TNP-470 may inhibit neuroblastoma growth in children if treatment is initiated following intensive multimodality therapy, when residual disease is minimal...
  6. ncbi request reprint Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma
    Rebecka L Meyers
    Division of Pediatric Surgery, Primary Children s Medical Center, University of Utah, Salt Lake City, UT 84113, USA
    J Pediatr Surg 42:2050-6. 2007
    ..In this study, we aimed to determine the long-term outcome of patients with hepatoblastoma who have a surgical resection of pulmonary metastatic lesions...
  7. ncbi request reprint Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents
    Sharon B Murphy
    Children s Cancer Research Institute, University of Texas Health Science Center, San Antonio 78229, USA
    J Pediatr Hematol Oncol 25:684-7. 2003
    ..To see if children and adolescents could be spared the adverse sequelae of treatment, the authors adopted a policy of little or no treatment of localized LPHD in 1989...
  8. ncbi request reprint Metastatic malignant rhabdoid tumor of the liver treated with tandem high-dose therapy and autologous peripheral blood stem cell rescue
    Howard M Katzenstein
    Med Pediatr Oncol 40:199-201. 2003
  9. doi request reprint Redefining the role of doxorubicin for the treatment of children with hepatoblastoma
    Marcio H Malogolowkin
    Childrens Hospital Los Angeles, Division of Hematology Oncology, 4650 Sunset Blvd, MS 54, Los Angeles, CA 90027, USA
    J Clin Oncol 26:2379-83. 2008
    ..However, international cooperative groups still favor the CD combination. We therefore decided to revisit the role of doxorubicin for the treatment of HB...
  10. ncbi request reprint Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study
    Morris Kletzel
    Department of Pediatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
    J Clin Oncol 20:2284-92. 2002
    ....
  11. ncbi request reprint Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study
    Howard M Katzenstein
    Department of Pediatrics and Surgery, Northwestern University and Children s Memorial Hospital, Chicago, IL, USA
    J Clin Oncol 20:3438-44. 2002
    ....
  12. ncbi request reprint Predictive value of staging systems in hepatoblastoma
    Rebecka L Meyers
    J Clin Oncol 25:737; author reply 737-8. 2007
  13. ncbi request reprint Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects
    Bruno De Bernardi
    Department of Haematology Oncology, Giannina Gaslini Children s Hospital, Largo Gerolamo Gaslini, 5, 16148 Genova, Italy
    Cancer Lett 228:283-99. 2005
    ....
  14. ncbi request reprint Gastrointestinal stromal tumors arising from the stomach: a report of three children
    Megan M Durham
    Department of Surgery, Children s Healthcare of Atlanta at Egleston and Emory University, Atlanta, GA 30322, USA
    J Pediatr Surg 39:1495-9. 2004
    ..Gastrointestinal stromal tumors (GIST) are a unique subset of intestinal mesenchymal tumors that behave in an aggressive fashion. They have been commonly described in adults but have been rarely observed in children...
  15. ncbi request reprint Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma
    Howard M Katzenstein
    Division of Hematology Oncology, Department of Pediatrics, Northwestern University, Children s Memorial Hospital, 2300 Children s Plaza, Box 30, Chicago, IL 60614, USA
    J Clin Oncol 22:3909-15. 2004
    ..To investigate whether response to induction therapy, evaluated by metaiodobenzylguanadine (MIBG) and bone scintigraphy, correlates with event-free survival (EFS) in children with high-risk neuroblastoma (NB)...
  16. ncbi request reprint Advances in the diagnosis and treatment of neuroblastoma
    Joanna L Weinstein
    Department of Pediatrics and Robert H Lurie Comprehensive Cancer Center, Northwestern University, The Feinberg School of Medicine, Chicago, Illinois, USA
    Oncologist 8:278-92. 2003
    ..This review discusses the current risk-based treatment approaches for children with neuroblastoma and recent advances in biologic therapy...
  17. ncbi request reprint Novel therapeutic approaches in the treatment of children with hepatoblastoma
    Howard M Katzenstein
    Division of Hematology Oncology, Department of Pediatrics, Northwestern University and Children s Memorial Hospital, Chicago, IL, USA
    J Pediatr Hematol Oncol 24:751-5. 2002
    ..Further exploration of the use of irinotecan is warranted in high-risk patients with hepatoblastoma...
  18. ncbi request reprint Increased microvascular density predicts relapse in Wilms' tumor
    Lisa P Abramson
    Division of Pediatric Surgery, Children s Memorial Hospital, Department of Biostatistics, Northwestern University Medical School, Chicago, Illinois 60611, USA
    J Pediatr Surg 38:325-30; discussion 325-30. 2003
    ..The authors postulated that increased microvascular density (MVD), a hallmark for angiogenesis, could identify patients at risk for relapse...